GRAIL, Inc.
GRAL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001699031
In the last 90 days, GRAIL, Inc. insiders filed 0 open-market purchases and 4 sales; 375 institutions reported holding it in 13F filings for Q2 2026, worth $2.60B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding GRAIL, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 0 | 2 | +2 |
| Shares | 0 | 135 | +135 |
| Value | $0 | $2.02K | +$2.02K |
New holders (2)
Institutions that held GRAIL, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shell Asset Management Co | 134 | $2.00K | 0.00% |
| Granite FO LLC | 1 | $15 | 0.00% |
Sold out (0)
Institutions that held GRAIL, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
None.